- Home
- TXMD vs UMH Comparison
TXMD vs UMH Comparison
Compare TXMD & UMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TXMD
- UMH
- Stock Information
- Founded
- TXMD 2008
- UMH 1968
- Country
- TXMD United States
- UMH United States
- Employees
- TXMD N/A
- UMH N/A
- Industry
- TXMD Biotechnology: Pharmaceutical Preparations
- UMH Real Estate Investment Trusts
- Sector
- TXMD Health Care
- UMH Real Estate
- Exchange
- TXMD Nasdaq
- UMH Nasdaq
- Market Cap
- TXMD 12.8M
- UMH 1.4B
- IPO Year
- TXMD N/A
- UMH N/A
- Fundamental
- Price
- TXMD $1.14
- UMH $17.15
- Analyst Decision
- TXMD
- UMH Strong Buy
- Analyst Count
- TXMD 0
- UMH 4
- Target Price
- TXMD N/A
- UMH $21.00
- AVG Volume (30 Days)
- TXMD 60.7K
- UMH 539.9K
- Earning Date
- TXMD 08-11-2025
- UMH 08-06-2025
- Dividend Yield
- TXMD N/A
- UMH 5.28%
- EPS Growth
- TXMD N/A
- UMH N/A
- EPS
- TXMD N/A
- UMH 0.10
- Revenue
- TXMD $1,841,000.00
- UMH $243,777,000.00
- Revenue This Year
- TXMD $427.09
- UMH $10.60
- Revenue Next Year
- TXMD N/A
- UMH $7.76
- P/E Ratio
- TXMD N/A
- UMH $164.16
- Revenue Growth
- TXMD 53.55
- UMH 8.17
- 52 Week Low
- TXMD $0.70
- UMH $15.74
- 52 Week High
- TXMD $2.44
- UMH $20.64
- Technical
- Relative Strength Index (RSI)
- TXMD 44.80
- UMH 55.22
- Support Level
- TXMD $0.98
- UMH $16.49
- Resistance Level
- TXMD $1.21
- UMH $17.04
- Average True Range (ATR)
- TXMD 0.09
- UMH 0.36
- MACD
- TXMD 0.00
- UMH 0.04
- Stochastic Oscillator
- TXMD 64.00
- UMH 93.15
About TXMD TherapeuticsMD Inc.
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.
About UMH UMH Properties Inc.
UMH Properties Inc together with its subsidiaries is a real estate investment trust. It is engaged in the business of ownership and operation of manufactured home communities - leasing manufactured homesites to residents . The Company also leases manufactured homes to residents and, through its wholly-owned taxable REIT subsidiary, UMH Sales and Finance, Inc. sells and finances the sale of manufactured homes to residents and prospective residents of its communities and for placement on customers' privately-owned land. The company also owns the land, utility connections, streets, lighting, driveways, common area amenities, and other capital improvements. It earns income from lease agreements for their sites and homes, where the company is the lessor.